Die Universität Regensburg ist eine in Regensburg angesiedelte bayerische Volluniversität mit rund 21.200 eingeschriebenen Studierenden im Wintersemester 2020/21.

During the past decade, University of Regensburg conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 5 clinical trials were completed, i.e. on average, 27.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Regensburg" #1 sponsor was "University of Regensburg" with 8 trials, followed by "Pfizer" with 3 trials sponsored, "European Society for Blood and Marrow Transplantation" with 2 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Regensburg" #1 collaborator was "University of Regensburg" with 3 trials as a collaborator, "ClinAssess GmbH" with 2 trials as a collaborator, "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator, "Acute Leukemia French Association" with 1 trials as a collaborator and "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator. Other collaborators include 47 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "University of Regensburg" are "Aneurysmal Subarachnoid Hemorrhage" (2 trials), "Depression" (2 trials), "Acute Graft-versus-Host Disease" (1 trials), "Acute Myeloid Leukemia" (1 trials) and "Advanced Melanoma" (1 trials). Many other conditions were trialed in "University of Regensburg" in a lesser frequency.

Most popular intervention types in "University of Regensburg" are "Drug" (18 trials), "Device" (8 trials), "Other" (4 trials), "Behavioral" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "placebo" (2 trials), "Adaptive Servo Ventilation" (1 trials), "Armodafinil 100 to 250 mg/day" (1 trials) and "Budesonide" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Regensburg" are 38 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Regensburg". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in University of Regensburg, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in University of Regensburg, 5 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".

University of Regensburg has several departments that took part in Clinical trials: "University of Regensburg- Dept of Psychiatry" - 2 trials, "Department of Neurology, Universty of Regensburg" - 2 trials, "Akadem. Lehrkrankenhaus der Uni Regensburg, Klinik für Urologie" - 2 trials